Core Points - Guangdong Xianglu Tungsten Industry Co., Ltd. has completed its response to the Shenzhen Stock Exchange regarding the inquiry letter for issuing shares to specific targets [1] - The company received the inquiry letter on November 12, 2025, and has updated its fundraising documents based on the third-quarter report [1] - The issuance of A-shares is subject to approval from the Shenzhen Stock Exchange and the China Securities Regulatory Commission, with uncertainties regarding the approval process and timeline [1] Summary by Category - **Company Actions** - The company has responded to the inquiry from the Shenzhen Stock Exchange and updated its fundraising documents accordingly [1] - The updated documents were disclosed on the Giant Tide Information Network [1] - **Regulatory Context** - The inquiry letter was officially numbered as Inquiry Letter [2025] 120052 [1] - The company emphasizes that the issuance of shares requires further approval from regulatory bodies, indicating potential uncertainties in the process [1] - **Financial Reporting** - The updates to the fundraising documents include financial data from the third-quarter report of 2025 [1]

奥特佳公告，公司于2025年12月2日收到深圳证券交易所上市审核中心出具的《关于奥特佳新能源科技 集团股份有限公司申请向特定对象发行股票的审核中心意见告知函》。深交所上市审核中心对公司向特 定对象发行股票的申请文件进行了审核，认为公司符合发行条件、上市条件和信息披露要求，后续深交 所将按规定报中国证监会履行相关注册程序。公司本次向特定对象发行股票事项尚需获得中国证监会同 意注册后方可实施，最终能否获得中国证监会同意注册的批复及其时间尚存在不确定性。 ...

中国经济网北京12月2日讯 高乐股份(002348.SZ)今日复牌，股价一字涨停，截至发稿报5.29元，上涨9.98%，总市值50.11亿元。 值得注意的是，停牌前最后一个交易日，即2025年11月24日，高乐股份涨停，收涨10.07%。 高乐股份昨晚披露了关于控股股东签署《股份转让协议》及公司签署《附条件生效的股份认购协议》暨公司控股股东、实际控制人拟 发生变更的提示性公告显示。 2025年11月30日，华统集团有限公司（以下简称"华统集团"）与北京黎曼云图科创有限公司（以下简称"黎曼云图"）签署《股权转让 协议》、《表决权委托协议》，华统集团将其持有的94,720,000股股份（占公司总股本的10%）转让给黎曼云图、华统集团将其持有的 37,888,000股股份（占公司总股本的4%）对应的表决权委托给黎曼云图行使。 2025年11月30日，杨广城、興昌塑膠五金廠有限公司与北京黎曼云图科创有限公司签署《表决权委托协议》，杨广城、興昌塑膠五金 廠有限公司分别将其持有的58,222,668股股份（占公司总股本的6.15%）和15,087,960股股份（占公司总股本的1.59%）对应的表决权委托给 黎曼云图行使。 ...

软通动力本次拟向特定对象发行股票，拟发行数量不超过2.86亿股，预计募集资金33.48亿元。本次发行 保荐机构为中信建投（601066）证券股份有限公司。 软通动力（301236）向特定对象发行股票申请审核状态变更为提交注册。 ...

Core Viewpoint - Meidike (688079.SH) has disclosed a plan for a private placement of A-shares for the year 2025, targeting specific qualified investors, with a total fundraising amount not exceeding RMB 700 million [1][2]. Summary by Sections Issuance Details - The private placement will involve no more than 35 specific investors, including various financial institutions and qualified individual investors [1]. - The issuance price will be set at no less than 80% of the average trading price over the previous 20 trading days prior to the pricing date [1][2]. - The type of shares issued will be domestic listed RMB ordinary shares (A-shares) with a par value of RMB 1.00 per share [2]. Fundraising and Investment Plans - The total number of shares to be issued will not exceed 30% of the company's total share capital prior to the issuance, amounting to a maximum of 122,577,359 shares [2]. - The total fundraising amount is capped at RMB 700 million, which will be allocated to three main projects: 1. MEMS device optical system manufacturing project: RMB 300 million 2. Semiconductor process bonding prism industrialization project: RMB 200 million 3. Supplementing working capital: RMB 200 million [2][3]. Shareholder Structure - The actual controller of the company is Ge Wenzhi, who holds 0.42% of the shares directly and controls 54.88% indirectly, maintaining control post-issuance [4]. - The issuance will not alter the control structure of the company, as Ge Wenzhi's shareholding will remain at 42.53% after the issuance, assuming no participation in the subscription [4]. Financial Performance - For the third quarter of 2025, the company reported revenue of RMB 160.42 million, a year-on-year increase of 26.91%, but a net loss attributable to shareholders of RMB -31.13 million [6][7]. - Year-to-date revenue reached RMB 451.13 million, reflecting a 32.04% increase, with a net loss of RMB -81.77 million [6][7]. - In 2023, the company experienced a revenue decline of 22.48%, with a net loss of RMB -84.45 million [8].

Core Points - The company has received an inquiry letter from the Shenzhen Stock Exchange regarding its application for a private placement of shares [1][2] - The company, along with relevant intermediaries, has provided detailed responses to the questions raised in the inquiry letter and updated the prospectus and related application documents [2] - The private placement of shares is subject to approval from the Shenzhen Stock Exchange and registration consent from the China Securities Regulatory Commission, with uncertainties regarding the approval timeline [2] Financial Data Updates - The company has updated the financial data in the prospectus in accordance with the disclosure of its third-quarter report for 2025 [2] - Specific financial figures and changes have been detailed in the announcements made on the Giant Tide Information Network [2]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603901 证券简称：永创智能 公告编号：2025-102 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： ●限制性股票登记日：2025年11月28日 ●限制性股票登记数量：292.80万股 根据中国证监会《上市公司股权激励管理办法》、上海证券交易所、中国证券登记结算有限责任公司上 海分公司有关规则的规定，杭州永创智能设备股份有限公司（以下简称"公司"）已于近日完成了《杭州 永创智能设备股份有限公司2025年第二期限制性股票激励计划》限制性股票授予登记工作，现将有关情 况公告如下： 一、限制性股票授予情况 2025年10月20日，公司召开第五届董事会第二十八次会议审议通过了《关于向2025年第二期限制性股票 激励计划激励对象授予限制性股票的议案》。董事会薪酬与考核委员会会对本次激励计划的授予激励对 象名单进行了审核。本次限制性股票授予具体情况如下： 转债代码：113654 转债简称：永02转债 杭州永创智能设备股份有限公司 关于2025年第二期 ...

Group 1 - TaLong Pharmaceutical's controlling shareholder is planning a major matter, leading to a suspension of trading starting December 2, 2025, with an expected suspension period of no more than 2 trading days [1] - WeiLing Co., Ltd. is set to resume trading on December 2, 2025, after a control change agreement was signed, involving the transfer of 2,023,380 shares (7.7646% of total shares) to Tibet ShanNan Antimony Resources Co., Ltd. [2][3] - ST SuWu received a decision for stock delisting, with the last trading date expected to be December 29, 2025, entering a 15-day delisting adjustment period starting December 9, 2025 [4] Group 2 - Zhongjin Irradiation disclosed a plan to issue A-shares to specific investors, raising up to 800 million yuan for various projects, including sterilization technology centers [5] - Yingtai Energy plans to repurchase shares worth 300 million to 500 million yuan for cancellation, with a maximum repurchase price of 2.50 yuan per share [9] - The company Huayi Group has approved a plan to repurchase shares worth between 30 million and 50 million yuan for employee stock ownership plans [9] Group 3 - The company Chuanqi Technology is planning to issue A-shares to Hefei State-owned Capital Venture Investment Co., which may lead to a change in control [15] - BYD reported November 2025 new energy vehicle sales of 480,200 units, a decrease from 506,800 units in the same month last year, with a cumulative sales increase of 11.3% year-on-year [15] - The company Zhenhua Technology approved the acquisition of 51% stakes in Shenzhen Betel Electronics and Shanghai Tongtu Semiconductor, with total transaction amounts of 321 million yuan and 357 million yuan, respectively [16]

高乐股份公告，拟向特定对象发行A股股票，发行数量不超过1.33亿股(含本数)，发行价格为3.7元/股。 募集资金总额不超过4.91亿元，扣除发行费用后将全部用于补充流动资金。本次发行对象为北京黎曼星 图科技合伙企业(有限合伙)，发行对象以现金全额认购本次发行的股票。 ...

Core Points - Hangzhou Changchuan Technology Co., Ltd. has completed its response to the Shenzhen Stock Exchange's inquiry regarding its application for a private placement of shares, and has updated the relevant application documents [1][2] - The issuance of shares is subject to approval from the Shenzhen Stock Exchange and registration by the China Securities Regulatory Commission, with an uncertain timeline for these processes [1][2] Summary by Sections - **Company Announcement**: On November 28, 2025, the company announced that it had completed its response to the inquiry from the Shenzhen Stock Exchange regarding its application for a private placement of shares, and updated the relevant application documents [1] - **Regulatory Process**: The company stated that the issuance of shares requires the completion of the Shenzhen Stock Exchange's review process and approval from the China Securities Regulatory Commission, indicating that the timeline for these approvals is uncertain [2]